Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Existing shareholders Atlas Venture and Partners Innovation Fund (PIF), plus new backer The Medicines Co. (TMC), have led an $8mm Series A financing for Annovation Biopharma Inc. (anesthetics and critical care medicines). The round may be expanded to $11mm. Atlas Venture Development Corp. managing director David Grayzel, MD, has joined as executive chairman of the board, and Atlas, PIF, and TMC have contributed board members.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?